Updated:
KARL STORZ Endoscopy-America
Sybill Storz's KARL STORZ Endoscopy-America runs the US commercial operations for the world's dominant private endoscopy group from El Segundo, CA.
KARL STORZ Endoscopy-America
KARL STORZ Endoscopy-America, founded in 1971, is the US commercial subsidiary of KARL STORZ SE & Co. KG, the German family-owned medical device group. Dr. Karl Storz started the parent company in 1945, and his daughter Sybill Storz has led the group since 1996. The American arm is not a separate public entity but the North American operating hub for a group that has remained privately held across three generations — an unusual structure for a device company of its scale. The wealth originates entirely from the design, manufacture, and sale of endoscopes and surgical imaging equipment. The subsidiary deploys capital into a direct-sales force, clinical training infrastructure, and US-based logistics. Unlike many European medtech exporters, KARL STORZ runs its own American sales organization rather than relying on distributors. Its product lines span rigid and flexible endoscopy, surgical camera systems, OR integration and documentation platforms, and instrument reprocessing. Confirmed US hospital networks and ambulatory surgery center relationships include partnerships with systems in urology, gynecology, general surgery, and ENT. The firm's geographic footprint in the United States extends from the El Segundo headquarters to regional offices and training centers in the Northeast and Midwest, supporting a direct clinical education model that functions as a competitive moat. Team size and revenue are not publicly reported. The US workforce includes field-service engineers, clinical educators, and a corporate infrastructure that reports back to the Tuttlingen-based parent. Known adjacent vehicles include the KARL STORZ Foundation, which supports medical research and education. In September 2024, the firm broke ground on a new $75 million, 180,000-square-foot US headquarters and training center in El Segundo, signaling a physical bet on continued American market expansion. Structurally, KARL STORZ Endoscopy-America operates as a wholly-owned distribution and service arm of a private, family-controlled German industrial group — an architecture that allows the parent to retain full profit from the world's largest healthcare market without dilutive capital partners, while using the US entity to run its own surgical-training university that locks in clinician loyalty.
General information
Firm type
Asset Manager
Year founded
1971
AUM
Undisclosed
Location
Region
North America
Country
United States
City
El Segundo
Corporate office
El Segundo, CA, United States
Additional offices
Tuttlingen, Germany (Global HQ)
Principals
Sybill Storz
Managing Director
Karl-Christian Storz
Member of the Management Board
Sector focus
Frequently asked questions
Who controls KARL STORZ Endoscopy-America and the broader KARL STORZ group?
Sybill Storz, daughter of founder Dr. Karl Storz, has led the group as Managing Director since 1996. Her son, Karl-Christian Storz, serves on the management board, representing the third generation. The group is a privately held German SE & Co. KG, and no outside investors hold equity. The US subsidiary is wholly owned and reports to the Tuttlingen parent.
How does KARL STORZ structure its US market presence?
KARL STORZ Endoscopy-America operates as a direct-sales and service organization rather than through third-party distributors. This structure allows the group to control clinical training, pricing, and customer relationships directly. The firm is building a new $75 million headquarters and training center in El Segundo to expand its US physician-education footprint, which functions as both a service and a retention tool.
Is KARL STORZ a public company, and does the firm disclose financials?
No. KARL STORZ SE & Co. KG is one of the largest privately held medical device companies in the world. It does not publish revenue, AUM, or deployment figures. The group has maintained this posture since its founding in 1945, and it has no disclosed outside investors or private equity backing.
What hospitals and surgery centers does KARL STORZ Endoscopy-America serve?
The firm supplies integrated operating-room solutions — including endoscopes, camera systems, and digital documentation — to thousands of US hospitals and ambulatory surgery centers across urology, gynecology, general surgery, and ENT. Specific institutional relationships are not publicly disclosed, though industry reporting shows deep penetration in academic medical centers and large integrated delivery networks.
What product lines does KARL STORZ Endoscopy-America market directly in the US?
The US subsidiary markets the full KARL STORZ portfolio: rigid and flexible endoscopes, HD and 4K surgical camera systems, OR1 operating-room integration platforms, instrument reprocessing equipment, and procedure-specific hand instruments. Clinical specialties include urology, laparoscopy, arthroscopy, neuroendoscopy, and airway management.
How does the KARL STORZ Foundation relate to the operating business?
The KARL STORZ Foundation is a legally separate philanthropic entity that funds medical research, surgical education, and scientific projects. It is funded by the Storz family and the operating group but is not a shareholder in KARL STORZ SE & Co. KG. The foundation represents the family's long-term commitment to the clinical ecosystem that sustains the core device business.
Does KARL STORZ Endoscopy-America make venture investments or co-invest alongside external funds?
There is no public record of KARL STORZ Endoscopy-America operating as a venture or growth-equity investor. The group has historically invested its surplus cash flow into organic expansion, manufacturing infrastructure, and direct clinical education rather than into external fund commitments or portfolio-company investing.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: